Evaluating the Role of Antinuclear Antibody Testing in Systemic Lupus Erythematosus


This 15-minute accredited CME publication reviews the benefits and limitations of antinuclear antibody (ANA) testing and its utility in systemic lupus erythematosus (SLE). Highlights include an examination of ANA expression in SLE, the role of ANA testing in clinical trials, challenges associated with currently available assays, and novel approaches for ANA testing. In addition, this activity features a short video with expert commentary on ANA testing in SLE.

Online Publication
0.25 AMA PRA Category 1 Credit™

David Stephen Pisetsky, MD, PhD
Professor of Medicine
Professor of Immunology